Trials / Terminated
TerminatedNCT04232228
A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers
A UK Observational Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- Janssen-Cilag Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe the Crohn's Disease (CD)-related secondary healthcare resource utilisation of patients in the 6 months pre- and 12 months post-activation of Care4Today® inflammatory bowel disease (C4T IBD) alongside standard of care (SOC) in the management of CD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention was used in this study. |
Timeline
- Start date
- 2020-02-07
- Primary completion
- 2022-04-04
- Completion
- 2022-04-04
- First posted
- 2020-01-18
- Last updated
- 2025-04-27
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04232228. Inclusion in this directory is not an endorsement.